Improving breast cancer radiotherapy using advanced imaging and robotic technology
Precision breast radiotherapy with the soft robot and supine CT
This study is testing a new soft robotic system to help breast cancer patients stay still and be accurately targeted during radiotherapy, making the treatment more effective and comfortable while protecting healthy tissues nearby.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11136890 on NIH RePORTER |
What this research studies
This research focuses on enhancing the precision of radiotherapy for breast cancer patients by developing a soft robotic system that improves the immobilization and localization of the breast during treatment. The approach involves using advanced imaging techniques to accurately target tumors while minimizing exposure to surrounding healthy tissues, such as the heart and lungs. By addressing the unique biomechanical properties of the breast, the study aims to reduce both acute and chronic side effects associated with traditional radiotherapy methods. Patients will be positioned in a way that optimizes treatment effectiveness and comfort.
Who could benefit from this research
Good fit: Ideal candidates for this research are breast cancer patients undergoing radiotherapy who require precise targeting of tumors.
Not a fit: Patients with non-breast cancers or those who are not undergoing radiotherapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and safer radiotherapy options for breast cancer patients, significantly improving their quality of life.
How similar studies have performed: Previous research has shown promise in using advanced imaging and robotic technologies for improving radiotherapy outcomes, indicating a potential for success in this novel approach.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Sheng, Ke — University of California, San Francisco
- Study coordinator: Sheng, Ke
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.